We are live on ! Find out more
IBRN icon

iShares Neuroscience and Healthcare ETF
IBRN

2 hedge funds and large institutions have $4.89M invested in iShares Neuroscience and Healthcare ETF in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

98.49% more ownership

Funds ownership: 0% → 98.49% (+98%)

Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.64M
2
FTUS
Flow Traders U.S.
New York
+$1.14M

Top Sellers

No sellers this quarter

IBRN Hedge Fund Activity: Q3 2022 in Review

2 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q3 2022, worth a combined $4.89M.

Buyers outnumbered sellers: 2 funds opened new IBRN positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $3.64M.

  • 2 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q3 2022, up from 0 in Q2 2022.
  • Funds reported $4.89M of iShares Neuroscience and Healthcare ETF stock for Q3 2022.
  • 2 funds opened new iShares Neuroscience and Healthcare ETF positions in Q3 2022 and 0 closed out, a net change of +2 holders.
  • The largest iShares Neuroscience and Healthcare ETF buyer in Q3 2022 was BlackRock, an estimated $3.64M added.

Based on aggregated 13F filings for Q3 2022.